Osteoporosis and cardiovascular disease tend to co-occur in older adults.
Study investigates vascular dysfunction as mechanism underlying link between heart and bone health in older adultsmeasured vascular dysfunction in relation to bone loss and deterioration in bone microarchitecture to investigate whether this is due to shared risk factors or if there is a causal pathway by which vascular dysfunction with aging leads to skeletal fragility.
," the study found that while people with impaired blood vessel function tend to have lower bone density and worse deterioration in bone micro-structure, the association did not remain after statistically controlling for age, sex, and other confounders.
The Framingham Heart Study, Boston University, Beth Israel Deaconess Medical Center, and the Marcus Institute at Hebrew SeniorLife collaborated on this study.: Study investigates vascular dysfunction as mechanism underlying link between heart and bone health in older adults retrieved 9 July 2024 from https://medicalxpress.com/news/2024-07-vascular-dysfunction-mechanism-underlying-link.html
Medicine Research Health Research News Health Research Health Science Medicine Science
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Study reveals promising drug target for treating osteoporosisOsteoporosis is a skeletal condition that leads to the weakening of bones, making them porous, fragile, and prone to breakage. A whopping 8.9 million fractures are caused by osteoporosis annually, with one fracture occurring every three seconds.
Weiterlesen »
USPSTF recommends osteoporosis screening for women aged 65 years and olderThe U.S. Preventive Services Task Force (USPSTF) recommends screening for osteoporosis for women aged 65 years and older and for postmenopausal women younger than 65 years with one or more risk factors. These recommendations form the basis of a draft recommendation statement published online June 11.
Weiterlesen »
Gprc5a identified as potential drug target for treating osteoporosisOsteoporosis is a skeletal condition that leads to the weakening of bones, making them porous, fragile, and prone to breakage.
Weiterlesen »
Can we withdraw treatment in post-menopausal osteoporosis?Bisphosphonates are the recommended first-line treatment in post-menopausal osteoporosis, with denosumab recommended second-line.
Weiterlesen »
New gene linked to osteoporosis identifiedOsteoporosis—weakening of the bones with age—affects millions worldwide, and this figure is increasing annually as the global population ages. It is associated with the aging, or 'senescence,' of bone cells, but the underlying cell types and mechanisms were unclear.
Weiterlesen »
Deep learning for early osteoporosis risk predictionOsteoporosis is so difficult to detect in early stage it's called the 'silent disease.' What if artificial intelligence could help predict a patient's chances of having the bone-loss disease before ever stepping into a doctor's office?
Weiterlesen »